Brain Cancer Vaccine Shows 66% Survival After 8 Years

A groundbreaking vaccine targeting a common mutation in deadly brain tumors helped two-thirds of patients survive eight years in a clinical trial.

The treatment trains the immune system to hunt down cancer cells carrying the genetic error found in most gliomas.